Institutional investors purchased a net $24.7 thousand shares of NNVC during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 9.67% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE COLONY GROUP LLC Bought 85.7 Thousand shares of NanoViricides Inc
THE VANGUARD GROUP, INC. Bought 69.5 Thousand shares of NanoViricides Inc
DEUTSCHE ASSET & WEALTH MANAGEME... Bought 66.0 Thousand shares of NanoViricides Inc